Dexcom a annoncé lundi prévoir un chiffre d'affaires préliminaire d'environ 1,26 milliard USD pour le quatrième trimestre, ...
DexCom, Inc. reduced its 2024 revenue guidance following a decline in new U.S. customers and revenue per customer, leading to a sharp share price drop, despite $750 million share buyback. DexCom faces ...
DexCom, Inc. a publié des indications préliminaires non auditées concernant ses résultats pour le quatrième trimestre et ...
Barclays a noté qu’Abbott étend davantage sa présence dans les segments principaux de DexCom, à savoir le diabète de type 1 et le diabète de type 2 nécessitant de l’insuline, tandis que DexCom a connu ...
Dexcom’s continuous blood glucose monitoring systems help people living with diabetes track their blood sugar levels. The device connects to a person’s skin and provides continuous feedback to an app ...
DexCom's returns over the past decade have been solid, but not quite on par with the market's. The company has encountered some headwinds in recent years that have sunk its stock price. Despite the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback